Publication Name	World Journal of Gastroenterology
Manuscript ID	9809
Country	China

Received	2014-03-01 12:35
Peer-Review Started	2014-03-01 19:18
To Make the First Decision	2014-03-27 21:12
Return for Revision	2014-03-31 10:12
Revised	2014-05-08 00:00
Second Decision	2014-05-26 21:33
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-05-26 21:55
Articles in Press	2014-05-26 22:08
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-06-09 18:14
Typeset the Manuscript	2014-10-13 17:12
Publish the Manuscript Online	2014-10-29 19:34

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Meta-Analysis
Article Title	Standard triple therapy for Helicobacter pylori infection in China: A meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Ben Wang, Zhi-Fa Lv, You-Hua Wang, Hui Wang, Xiao-Qun Liu, Yong Xie and Xiao-Jiang Zhou
Funding Agency and Grant Number	Funding Agency Grant Number National Science and Technology Major Projects for “Major New Drugs Innovation and Development” of China 2011ZX09302-007-03
Corresponding Author	Yong Xie, MD, PhD, Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, No. 17 Yongzhengwai Street, Donghu District, Nanchang 330000, Jiangxi Province, China. xieyong_med@163.com
Key Words	Helicobacter pylori; Eradication; Combination drug therapy; Amoxicillin; Clarithromycin; Adverse effects; Meta-analysis
Core Tip	This study compared the efficiency of standard triple therapy with other pre-existing and new therapies on the Chinese mainland and examined the eradication rates for Helicobacter pylori in China. The results showed that the standard triple therapy including proton pump inhibitors, amoxicillin and clarithromycin might not be suitable for first-line therapy.
Publish Date	2014-10-29 19:34
Citation	Wang B, Lv ZF, Wang YH, Wang H, Liu XQ, Xie Y, Zhou XJ. Standard triple therapy for Helicobacter pylori infection in China: A meta-analysis. World J Gastroenterol 2014; 20(40): 14973-14985
URL	http://www.wjgnet.com/1007-9327/full/v20/i40/14973.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i40.14973

Full Article (PDF)	WJG-20-14973.pdf
Full Article (Word)	WJG-20-14973.doc
Manuscript File	9809-Review.doc
Answering Reviewers	9809-Answering reviewers.pdf
Copyright License Agreement	9809-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	9809-Language certificate.pdf
Peer-review Report	9809-Peer review.pdf
Scientific Misconduct Check	9809-CrossCheck.jpg
Scientific Editor Work List	9809-Scientific editor work list.pdf